- Olympus Assumes Commercial Activities for VERSAPOINT™ – Electrosurgery System for Intrauterine Pathologies from Ethicon

Tokyo / Hamburg, October 15, 2019. Olympus Corporation (President and CEO: Yasuo Takeuchi) announced today that Olympus and Ethicon, Inc. have entered an agreement in which Olympus will take over all new commercial activities related to the VERSAPOINT™ Electrosurgery system from Ethicon. With this agreement, Olympus will acquire new channels in its Gynecology Business toward its goal of bringing patients and customers more minimally invasive technology and product options.

For several years Olympus’ subsidiary, Gyrus Medical Ltd, has supplied Gynecare (part of Ethicon) with resectoscopes, generators and electrodes that together comprise the VERSAPOINT™ Bipolar Electrosurgery System. The VERSAPOINT™ system is used and trusted by healthcare practitioners worldwide for the treatment of various intrauterine pathologies such as myomas, polyps, intrauterine adhesions and uterine septa. In addition to continuing to manufacture the products, pursuant to the new agreement Olympus will take over all new commercial sales and marketing activities related to VERSAPOINT™ starting from 1 January 2020. As part of the transaction, Olympus will also acquire the VERSAPOINT™ trademark. Going forward, the current VERSAPOINT™ resectoscope will be phased out and replaced with Olympus’ OES Pro 8,5mm resectoscope.
The companies anticipate that Olympus will take over commercial activities in most European countries and the U.S.(*), as well as countries in which only an EU declaration of conformity is required for marketing of VERSAPOINT™ products, starting from 1 January 2020. Ethicon will continue to provide VERSAPOINT™ products to customers in certain other territories until applicable regulatory approvals have been obtained, at which point Olympus will take on sales and marketing activities in these countries. Olympus will also offer repair services for the VERSAPOINT™ generators (subject to local availability). The Versascope hysteroscope does not form part of the agreement and will remain with Ethicon.
Manisha Shah-Bugaj, Global Head of Olympus’ Gynecology Business, commented, “We believe that the VERSAPOINT™ Electrosurgery system will form an important and highly complementary part of Olympus’ product offering, supporting our strategy of offering best in class, minimally invasive treatments to gynecologists. We will continue developing our business to support more customers and patients as a global medtech company.”

*The products are not yet authorized for marketing by Olympus in the U.S.

General note: Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Olympus representative if you have questions about the availability of specific Olympus products in your area.

About Olympus
Since our founding in 1919, Olympus has thrived on our pioneering spirit of innovation, crafting groundbreaking solutions in the medical, scientific, and imaging fields. A global medtech company with more than 35,000 employees in locations in nearly 40 countries, we are committed to helping make people’s lives healthier, safer and more fulfilling around the world.

About Olympus Europa
Olympus Europa is the headquarters for the region EMEA (Europe, Middle East, and Africa) of the Olympus Corporation, Tokyo, Japan. As a worldwide leading manufacturer of optical and digital precision technology, Olympus provides innovative solutions for state-of-the-art medical systems, digital cameras as well as scientific solutions. The company’s award-winning products are instrumental in detecting, preventing and healing illness, driving scientific research and documenting life with artistic freedom. In the hands of its customers, Olympus’ high-tech products help to make people’s lives healthier, safer and more fulfilling.


Matthias Gengenbach

+49 40 23773 5867






Via Dell'industria, 65
01100 Viterbo - Italy
T +39 0761 352198
F +39 0761 352133
VAT: IT01612570562

INFODENT SRL has been operating in the dental market for 20 years. Our main product is INFODENT INTERNATIONAL B2B magazine, mailed worldwide to 20,500 companies in the dental trade and industry.We provide customised B2B marketing services and consultancy to help companies in the dental trade and industry find international partners, expand into new markets and promote their brand on an international scale.Since 2003 we have expanded our activity to the whole medical sector through INFOMEDIX INTERNATIONAL, our B2B medical magazine, and a range of related marketing services.

© 2022 Infomedix International. - All rights reserved

Forgot your password? Enter the email address for your account.
An email will be sent allowing you to reset it.